Related Articles
Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Autophagy controls programmed death‑ligand 1 expression on cancer cells (Review)
Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment (Review)
PD‑L1 expression levels on tumor cells affect their immunosuppressive activity